Investors Purchase High Volume of Astera Labs Call Options (NASDAQ:ALAB)

Astera Labs, Inc. (NASDAQ:ALAB) saw unusually large options trading on Wednesday. Stock investors purchased 36,322 call options on the company. This represents an increase of approximately 28% compared to the typical volume of 28,406 call options.

Insider Transactions at Astera Labs

In related news, COO Sanjay Gajendra sold 230,639 shares of the business’s stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $198.22, for a total value of $45,717,262.58. Following the completion of the sale, the chief operating officer directly owned 664,361 shares in the company, valued at approximately $131,689,637.42. The trade was a 25.77% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the business’s stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $200.03, for a total value of $701,105.15. Following the completion of the sale, the director owned 63,639 shares of the company’s stock, valued at approximately $12,729,709.17. This trade represents a 5.22% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,290,546 shares of company stock worth $211,225,088 over the last quarter. Company insiders own 12.50% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. Assetmark Inc. grew its stake in Astera Labs by 374.1% in the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after buying an additional 101 shares in the last quarter. Reflection Asset Management purchased a new position in Astera Labs in the 4th quarter valued at approximately $25,000. Smartleaf Asset Management LLC grew its stake in Astera Labs by 422.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after buying an additional 152 shares in the last quarter. Hilltop National Bank grew its stake in Astera Labs by 100.0% in the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after buying an additional 100 shares in the last quarter. Finally, Aventura Private Wealth LLC purchased a new position in shares of Astera Labs during the 4th quarter valued at $33,000. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Astera Labs Stock Performance

NASDAQ:ALAB traded up $33.22 on Wednesday, hitting $277.48. The stock had a trading volume of 5,330,727 shares, compared to its average volume of 5,441,338. The stock has a market cap of $47.56 billion, a P/E ratio of 188.03, a price-to-earnings-growth ratio of 2.85 and a beta of 3.35. Astera Labs has a 1 year low of $84.78 and a 1 year high of $280.90. The firm’s fifty day simple moving average is $159.81 and its two-hundred day simple moving average is $157.14.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. During the same quarter last year, the business posted $0.33 EPS. Astera Labs’s quarterly revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities research analysts predict that Astera Labs will post 1.84 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the stock. Weiss Ratings raised shares of Astera Labs from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, May 6th. UBS Group started coverage on shares of Astera Labs in a research report on Tuesday, April 21st. They set a “neutral” rating and a $180.00 price target on the stock. Barclays increased their price objective on shares of Astera Labs from $165.00 to $200.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 7th. Citigroup raised their price target on shares of Astera Labs from $200.00 to $245.00 and gave the company a “buy” rating in a research report on Wednesday, May 6th. Finally, Royal Bank Of Canada raised their price target on shares of Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a research report on Wednesday, May 6th. Fifteen research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to data from MarketBeat, Astera Labs presently has a consensus rating of “Moderate Buy” and a consensus price target of $233.75.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.